• linkedin
  • Increase Font
  • Sharebar

    AUA '17 puts emphasis squarely on 'value'

    New era of value-based care permeates policy, clinical presentations


    Localized Prostate Cancer Treatment

    Leonard G. Gomella, MDDr. GomellaHow MRI use affects management of localized prostate cancer and the nuances of focal therapy are two of the hot topics in localized prostate cancer at this year’s meeting, according to Leonard G. Gomella, MD, professor and chairman of urology at Thomas Jefferson University, Philadelphia.

    “The robot frenzy seems to be dying down and the interest in focal therapy seems to be the flavor of this year’s group of AUA papers,” Dr. Gomella said.

    Here are Dr. Gomella's abstract picks in localized prostate cancer treatment:

    MP47-10: MRI use alters prostate cancer management patterns: Treatment trends in the image-guided biopsy era.

    Joseph A. Baiocco


    MP70-03: Clinical performance of multi parametric magnetic resonance imaging in the follow-up of partial gland ablation for prostate cancer

    Arjun Sivaraman


    MP70-05: Defining the index lesion for salvage partial gland ablation after radiation therapy for localized prostate cancer

    Arjun Sivaraman


    MP70-06: Predicting oncological control following focal ablation (FA) of prostate cancer (PCa)

    Alexander Kenigsberg


    MP70-10: New approach to focal therapy of localized prostate cancer with “fusion” integrated path and high intensity focused ultrasound (HIFU): Initial experience

    Alessandro Branchi


    MP70-12: Predicting extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer

    Toshikazu Takeda


    MP93-16: Impact of obesity on prostate cancer recurrence after radical prostatectomy

    Vidit Sharma


    MP93-19: Prostate MRI prior to prostatectomy does not impact surgical outcomes

    Eric Kim


    PD10-09: Effect of dehydrated human amnion/chorion membrane allograft on urinary continence following robot-assisted radical prostatectomy

    Khaled Refaai


    PD51-11: Pathological findings at radical prostatectomy after initial active surveillance in low-risk prostate cancer patients. Did we miss the chance to cure?

    Nazareno Suardi

    Richard R. Kerr
    Kerr is group content director for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available